What Worked and What Didn't This Earnings Season

The discussion was broadly mixed: S&P 500 earnings were reported up 28% year over year, with 85% of companies beating EPS estimates and average beats more than 18% above consensus, but inflation remained hot at 3.8% CPI and 6.0% PPI, pushing rates higher. The panel highlighted strength in AI-related capex, but also caution around frothy IPOs, weak restaurant and apparel demand, and rising consumer pressure. Stock ideas centered on Intuitive Surgical, Darden, Nike, C.H. Robinson, and Starbucks, with Starbucks also announcing another round of layoffs.

Analysis

The tape is telling us this is still a barbell market: AI capex and healthcare innovation are absorbing incremental capital, while consumer-discretionary names tied to traffic density and basket size are losing pricing power. The second-order effect is that the winners are increasingly the picks-and-shovels of spending rather than the end-demand brands themselves; that favors compute, automation, and diagnostics over restaurants and apparel, where unit growth is now colliding with saturation and lower-frequency consumption.

What the market may be missing is that “strong earnings” can coexist with fragile breadth when margin expansion is being financed by temporary spending intensity from a small cohort of hyperscalers and by a still-resilient upper-income consumer. If AI capex merely plateaus instead of accelerating, the earnings optics for hardware, power, and memory could deteriorate quickly even without an outright demand collapse. That makes the current winners more cyclically exposed than their valuations imply, especially where the market is extrapolating multi-year spend curves.

On the consumer side, the issue is not just traffic softness; it’s substitution pressure. GLP-1 adoption, higher food inflation, and a crowded fast-casual landscape all compress restaurant frequency and average ticket, while apparel faces easier brand replication and lower switching costs than in prior cycles. That’s why the better setup is not “cheap on multiples,” but businesses with either genuine moat durability or channel breadth that can survive a weaker middle-income consumer without requiring heroic same-store sales assumptions.

Key Decisions for Investors

• Long ISRG vs short SBUX into the next 1-2 quarters: robotics has durable procedure-driven demand while coffee is still priced for a turnaround that can be delayed by traffic softness and labor deleverage; target 15-20% relative outperformance if hospital budgets stabilize.
• Initiate a cautious long CAVA / short DENN pair for 6-12 months: CAVA still has whitespace and unit growth optionality, while DENN is a low-quality consumer proxy with limited pricing power; keep size modest because fast-casual multiples can mean-revert sharply.
• Prefer GEHC or BSX over TMDX on a 6-12 month horizon: both have steadier hospital adoption paths and less logistics execution risk; TMDX can work, but it is more vulnerable if capital spending slows or reimbursement gets scrutinized.
• Fade the more crowded AI-capex beneficiaries with tight risk controls: use a short basket of DELL against NVDA/MSFT/AMZN-linked enthusiasm only on failed follow-through days, since the trade works best if hyperscaler guidance flattens rather than accelerates.
• Treat NKE as a dividend hold, not a momentum buy: if the stock reclaims prior support while insider buying persists, it can offer 8-12% upside with income support; avoid UAA and be selective on ONON until pricing power proves durable beyond one more season.